Previous reports have shown that COX-1, not COX-2, is up-regulated in multiple genetically engineered mouse models of ovarian cancer [32, 33], suggesting that COX-1 has a pro-tumorigenic role. This evidence concerns the gene PTGS2 and ovarian carcinoma.